224 related articles for article (PubMed ID: 29599287)
21. Rationally designed inhibitor targeting antigen-trimming aminopeptidases enhances antigen presentation and cytotoxic T-cell responses.
Zervoudi E; Saridakis E; Birtley JR; Seregin SS; Reeves E; Kokkala P; Aldhamen YA; Amalfitano A; Mavridis IM; James E; Georgiadis D; Stratikos E
Proc Natl Acad Sci U S A; 2013 Dec; 110(49):19890-5. PubMed ID: 24248368
[TBL] [Abstract][Full Text] [Related]
22. Structural basis for antigenic peptide precursor processing by the endoplasmic reticulum aminopeptidase ERAP1.
Nguyen TT; Chang SC; Evnouchidou I; York IA; Zikos C; Rock KL; Goldberg AL; Stratikos E; Stern LJ
Nat Struct Mol Biol; 2011 May; 18(5):604-13. PubMed ID: 21478864
[TBL] [Abstract][Full Text] [Related]
23. Endoplasmic reticulum aminopeptidase 1 (ERAP1) trims MHC class I-presented peptides in vivo and plays an important role in immunodominance.
York IA; Brehm MA; Zendzian S; Towne CF; Rock KL
Proc Natl Acad Sci U S A; 2006 Jun; 103(24):9202-7. PubMed ID: 16754858
[TBL] [Abstract][Full Text] [Related]
24. Structural Basis for Antigenic Peptide Recognition and Processing by Endoplasmic Reticulum (ER) Aminopeptidase 2.
Mpakali A; Giastas P; Mathioudakis N; Mavridis IM; Saridakis E; Stratikos E
J Biol Chem; 2015 Oct; 290(43):26021-32. PubMed ID: 26381406
[TBL] [Abstract][Full Text] [Related]
25. The ER aminopeptidase ERAP1 enhances or limits antigen presentation by trimming epitopes to 8-9 residues.
York IA; Chang SC; Saric T; Keys JA; Favreau JM; Goldberg AL; Rock KL
Nat Immunol; 2002 Dec; 3(12):1177-84. PubMed ID: 12436110
[TBL] [Abstract][Full Text] [Related]
26. Crystal structures of the endoplasmic reticulum aminopeptidase-1 (ERAP1) reveal the molecular basis for N-terminal peptide trimming.
Kochan G; Krojer T; Harvey D; Fischer R; Chen L; Vollmar M; von Delft F; Kavanagh KL; Brown MA; Bowness P; Wordsworth P; Kessler BM; Oppermann U
Proc Natl Acad Sci U S A; 2011 May; 108(19):7745-50. PubMed ID: 21508329
[TBL] [Abstract][Full Text] [Related]
27. Cutting antigenic peptides down to size.
Natarajan K; Margulies DH
J Biol Chem; 2019 Dec; 294(49):18545-18546. PubMed ID: 31811048
[TBL] [Abstract][Full Text] [Related]
28. ERAP1-ERAP2 dimerization increases peptide-trimming efficiency.
Evnouchidou I; Weimershaus M; Saveanu L; van Endert P
J Immunol; 2014 Jul; 193(2):901-8. PubMed ID: 24928998
[TBL] [Abstract][Full Text] [Related]
29. Endoplasmic reticulum aminopeptidases: Biology and pathogenic potential.
Haroon N; Inman RD
Nat Rev Rheumatol; 2010 Aug; 6(8):461-7. PubMed ID: 20531381
[TBL] [Abstract][Full Text] [Related]
30. Structure-guided discovery of aminopeptidase ERAP1 variants capable of processing antigens with novel PC anchor specificities.
Pande S; Guo HC
Immunology; 2024 Jan; 171(1):131-145. PubMed ID: 37858978
[TBL] [Abstract][Full Text] [Related]
31. Critical Role of Interdomain Interactions in the Conformational Change and Catalytic Mechanism of Endoplasmic Reticulum Aminopeptidase 1.
Stamogiannos A; Maben Z; Papakyriakou A; Mpakali A; Kokkala P; Georgiadis D; Stern LJ; Stratikos E
Biochemistry; 2017 Mar; 56(10):1546-1558. PubMed ID: 28218509
[TBL] [Abstract][Full Text] [Related]
32. Separate effects of the ankylosing spondylitis associated ERAP1 and ERAP2 aminopeptidases determine the influence of their combined phenotype on the HLA-B*27 peptidome.
Martín-Esteban A; Sanz-Bravo A; Guasp P; Barnea E; Admon A; López de Castro JA
J Autoimmun; 2017 May; 79():28-38. PubMed ID: 28063628
[TBL] [Abstract][Full Text] [Related]
33. ERAP1-Dependent Antigen Cross-Presentation Determines Efficacy of Adoptive T-cell Therapy in Mice.
Schmidt K; Keller C; Kühl AA; Textor A; Seifert U; Blankenstein T; Willimsky G; Kloetzel PM
Cancer Res; 2018 Jun; 78(12):3243-3254. PubMed ID: 29559473
[TBL] [Abstract][Full Text] [Related]
34. Regulation of ERAP1 and ERAP2 genes and their disfunction in human cancer.
Compagnone M; Cifaldi L; Fruci D
Hum Immunol; 2019 May; 80(5):318-324. PubMed ID: 30825518
[TBL] [Abstract][Full Text] [Related]
35. Molecular pathways for antigenic peptide generation by ER aminopeptidase 1.
Mpakali A; Maben Z; Stern LJ; Stratikos E
Mol Immunol; 2019 Sep; 113():50-57. PubMed ID: 29678301
[TBL] [Abstract][Full Text] [Related]
36. Influence of ERAP1 and ERAP2 gene polymorphisms on disease susceptibility in different populations.
Yao Y; Liu N; Zhou Z; Shi L
Hum Immunol; 2019 May; 80(5):325-334. PubMed ID: 30797823
[TBL] [Abstract][Full Text] [Related]
37. Conformational dynamics linked to domain closure and substrate binding explain the ERAP1 allosteric regulation mechanism.
Maben Z; Arya R; Georgiadis D; Stratikos E; Stern LJ
Nat Commun; 2021 Sep; 12(1):5302. PubMed ID: 34489420
[TBL] [Abstract][Full Text] [Related]
38. To Be or Not to Be: The Case of Endoplasmic Reticulum Aminopeptidase 2.
Kuśnierczyk P
Front Immunol; 2022; 13():902567. PubMed ID: 35769458
[TBL] [Abstract][Full Text] [Related]
39. Critical role of endoplasmic reticulum aminopeptidase 1 in determining the length and sequence of peptides bound and presented by HLA-B27.
Chen L; Fischer R; Peng Y; Reeves E; McHugh K; Ternette N; Hanke T; Dong T; Elliott T; Shastri N; Kollnberger S; James E; Kessler B; Bowness P
Arthritis Rheumatol; 2014 Feb; 66(2):284-94. PubMed ID: 24504800
[TBL] [Abstract][Full Text] [Related]
40. Probing the S1 specificity pocket of the aminopeptidases that generate antigenic peptides.
Zervoudi E; Papakyriakou A; Georgiadou D; Evnouchidou I; Gajda A; Poreba M; Salvesen GS; Drag M; Hattori A; Swevers L; Vourloumis D; Stratikos E
Biochem J; 2011 Apr; 435(2):411-20. PubMed ID: 21314638
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
